| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Glenmark Life Sciences Ltd
NSE:GLS
Glenmark Life Sciences Ltd
Accounts Payable
Glenmark Life Sciences Ltd
Accounts Payable Peer Comparison
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
Accounts Payable
₹4.1B
|
CAGR 3-Years
23%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Accounts Payable
₹26.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Accounts Payable
₹24.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Accounts Payable
₹57B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Accounts Payable
₹21.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Accounts Payable
₹16.6B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
See Also
What is Glenmark Life Sciences Ltd's Accounts Payable?
Accounts Payable
4.1B
INR
Based on the financial report for Mar 31, 2024, Glenmark Life Sciences Ltd's Accounts Payable amounts to 4.1B INR.
What is Glenmark Life Sciences Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
17%
Over the last year, the Accounts Payable growth was 0%. The average annual Accounts Payable growth rates for Glenmark Life Sciences Ltd have been 23% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
